1 / 1

Custer Workplace Lecture Series Presents : Lecture by Dr. Ajit Narang Senior Research Investigator Drug Product Science & Technology , Bristol Myers Squibb “ Role of Nanotechnology in QbD Pharmaceutical Development” CEAS D-201 Friday , November 16, 2012 - 9:30-10:30 R efreshments at 9:00.

maxima
Download Presentation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Custer Workplace Lecture Series Presents:Lecture byDr. AjitNarangSenior Research Investigator Drug Product Science & Technology, Bristol Myers Squibb“Role of Nanotechnology in QbD Pharmaceutical Development”CEAS D-201Friday, November 16, 2012-9:30-10:30 Refreshments at 9:00 Pharmaceutical development is focused on achieving three key objectives while transforming a drug substance to a drug product: stability, bioavailability, and manufacturability. Focusing on the latter two, this seminar will provide case study examples of how material behavior and interactions at nanoscale are key to successful development of drug products in the current quality-by-design (QbD) paradigm. Using case studies from development, this presentation will further highlight areas of unmet need that can benefit from nanotechnology research.

More Related